ISMPP

21st Annual Meeting of ISMPP: A Summarized Report

The 21st Annual Meeting of ISMPP was held from May 12-14, 2025, in Washington, D.C. Cactus Life Sciences participated actively in the event, attending key sessions and engaging in discussions that explored the evolving landscape of medical publications. Our team walked away with powerful insights on how empathy, diversity, and AI are reshaping the future…...
Read More

Top Stories

NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers )?

The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered Survey Questionnaire and Responses

Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)

Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...
Pharma listening to patients

Ways Pharma Showed Patients How They Matter

Patient centricity is transforming the life sciences industry today. Here are outstanding examples of how...
Patient centricity in pharma

The Evolving State of Patient Centricity in the Pharmaceutical Industry

Patient centricity has been a point of discussion in pharma for years. Learn what patient...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging technology for patient centricity

Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs

As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...

Learn more ABOUT our company.